Daily reports from the 33rd European Clinical Neuropsychopharmacology (ECNP) Virtual Congress (12‒15 October 2020); and the 28th European Congress of Psychiatry (EPA) Virtual Congress (4–7 July 2020).
These conferences covered key issues related to child, adolescent and adult ADHD, clinical implications of scientific evidence, and new technologies for studying and managing ADHD. These reports give a daily overview of the presentations covered and their relevance to clinicians involved in the diagnosis and treatment of ADHD across the lifespan.
